Image Ben Hargreaves Patients Action by FDA ensures trial sponsors must consider diversity Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change. Market Access How the pandemic exposed faulty links in the supply chain The pandemic provided a harsh shock to healthcare, but proved particularly tough on the supply chains relied on to support public health. Patients Healthcare report finds declining public trust in institutio... There are few things more important than health, but a recent report suggests that the public has declining trust in traditional healthcare institutions to protect theirs. Market Access Is the UK’s healthcare spending drop sustainable? The UK’s health system has been under pressure to manage costs whilst still delivering a reliable service. Load more results
Patients Action by FDA ensures trial sponsors must consider diversity Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change.
Market Access How the pandemic exposed faulty links in the supply chain The pandemic provided a harsh shock to healthcare, but proved particularly tough on the supply chains relied on to support public health.
Patients Healthcare report finds declining public trust in institutio... There are few things more important than health, but a recent report suggests that the public has declining trust in traditional healthcare institutions to protect theirs.
Market Access Is the UK’s healthcare spending drop sustainable? The UK’s health system has been under pressure to manage costs whilst still delivering a reliable service.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
